Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

SCTE Launches Inaugural Fiber Blowing Credential and PNM Courses Backed By New Industry Advisory Council

April 30, 2026

New Jersey Families Can’t Wait. Learning Care Isn’t.

April 30, 2026

Indra Group USA to Showcase the Future of Smart Mobility, V2x Tolling, and Gantryless Solutions at the 2026 IBTTA Technology Summit

April 30, 2026

Momcozy Launches Clinically Tested Skincare Solutions for Breast and Belly Care

April 30, 2026

Poland Data Center Colocation Market Set to Double in Size During 2026-2030: Analysis of Emerging Investment Opportunities

April 30, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Obagi Medical Unveils New Mineral Sunscreen Designed to Protect Sensitive and Post-Procedure Skin*
Press Release

Obagi Medical Unveils New Mineral Sunscreen Designed to Protect Sensitive and Post-Procedure Skin*

By News RoomApril 30, 20264 Mins Read
Obagi Medical Unveils New Mineral Sunscreen Designed to Protect Sensitive and Post-Procedure Skin*
Share
Facebook Twitter LinkedIn Pinterest Email

NEW YORK, April 30, 2026 (GLOBE NEWSWIRE) — Obagi Medical (“Obagi”), a leader in advanced skincare innovation, the originator of medical-grade skincare and part of Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), today announced the launch of its latest innovation, Sun Shield™ Mineral UV Barrier Protect Broad Spectrum SPF 40, a clinically proven mineral sunscreen designed to deliver comprehensive UV protection while supporting skin health.

Formulated with 100% mineral active filters, antioxidants, ceramides, and squalane, this advanced sunscreen provides broad-spectrum UVA/UVB protection while helping to soothe, hydrate, and support the skin barrier. The lightweight, non-comedogenic formula is ideal for sensitive, acne-prone, and post-procedure* skin, making it a versatile addition to any daily skincare regimen.

“This launch represents the continued evolution of Obagi’s suncare portfolio,” said Justin Giouzepis, Chief Marketing Officer. “As the category shifts toward mineral-based, skincare-first protection, we developed this innovation to meet evolving consumer and channel needs while leveraging our medical-grade skincare expertise to strengthen our suncare offering as the first line of defense against premature skin aging and discoloration. This sunscreen delivers effective UV protection and reflects our commitment to high-performance, skincare-first SPF solutions that support a comprehensive daily regimen.”

This new addition to the Obagi Sun Shield™ portfolio reflects growing consumer demand for mineral-based sunscreens that deliver both efficacy and skin compatibility. According to internal insights, a majority of U.S. sunscreen users prefer mineral formulas, particularly those that support overall skin health and barrier function.

“Sun protection is the foundation of healthy skin, especially following professional treatments or when managing sensitivity,” said Dr. Suzan Obagi, Chief Medical Director. “With Sun Shield™ Mineral UV Barrier Protect SPF 40, we’ve combined high-performance mineral protection with restorative skincare ingredients to help patients protect and strengthen their skin every day.”

Sun Shield™ Mineral UV Barrier Protect Broad Spectrum SPF 40 provides broad-spectrum SPF 40 mineral UVA/UVB protection while supporting the skin barrier with ceramides and squalane. The formula also delivers antioxidant defense against photodamage and oxidative stress, and is dermatologist-tested to be lightweight, non-irritating, and non-comedogenic. It is suitable for sensitive, acne-prone, and post-procedure* skin.

Sun Shield™ Mineral UV Barrier Protect Broad Spectrum SPF 40 is now available for $65 on Obagi.com, Amazon.com, as well as through authorized Obagi Medical providers and select retail channels.

About Obagi Medical
Obagi Medical is an industry-leading, advanced skincare line rooted in research and skin biology, with a legacy of 35+ years of experience. Initially known for its leadership in the treatment of hyperpigmentation with the Obagi Nu-Derm® System, Obagi Medical products are designed to address a variety of skin concerns, including premature aging, photodamage, skin discoloration, acne, and sun damage. As the fastest-growing professional skincare brand in the U.S. in 2024**, Obagi Medical empowers individuals to achieve healthy, beautiful skin. More information about Obagi Medical is available on the brand’s website, https://www.obagi.com.

About Waldencast plc
Founded by Michel Brousset and Hind Sebti, Waldencast’s ambition is to build a global best-in-class beauty and wellness operating platform by developing, acquiring, accelerating, and scaling conscious, high-growth purpose-driven brands. Waldencast’s vision is fundamentally underpinned by its brand-led business model that ensures proximity to its customers, business agility, and market responsiveness, while maintaining each brand’s distinct DNA. The first step in realizing its vision was the Business Combination. As part of the Waldencast platform, its brands will benefit from the operational scale of a multi-brand platform; the expertise in managing global beauty brands at scale; a balanced portfolio to mitigate category fluctuations; asset light efficiency; and the market responsiveness and speed of entrepreneurial indie brands. For more information please visit: https://ir.waldencast.com.

Media Contact:
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/c1c7fdcd-0ae7-47ae-b896-4dd3d286f4e1

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

SCTE Launches Inaugural Fiber Blowing Credential and PNM Courses Backed By New Industry Advisory Council

New Jersey Families Can’t Wait. Learning Care Isn’t.

Indra Group USA to Showcase the Future of Smart Mobility, V2x Tolling, and Gantryless Solutions at the 2026 IBTTA Technology Summit

Momcozy Launches Clinically Tested Skincare Solutions for Breast and Belly Care

Poland Data Center Colocation Market Set to Double in Size During 2026-2030: Analysis of Emerging Investment Opportunities

UAE Data Center Colocation Market Databook Q2 2026: Hyperscale Investments Position UAE as Regional Cloud Gateway

Asset Preservation Wealth & Tax Expands Southeast Presence with New Greenville, South Carolina, Office

Ground Breaking for Intermountain Health Fillmore Community Hospital Emergency Department Expansion Will Enhance Access to Care in Region

Pharmacovigilance and Drug Safety Software Market Report 2026 Featuring Profiles of IQVIA, Oracle Corporation, ArisGlobal, and RXLogix

Editors Picks

New Jersey Families Can’t Wait. Learning Care Isn’t.

April 30, 2026

Indra Group USA to Showcase the Future of Smart Mobility, V2x Tolling, and Gantryless Solutions at the 2026 IBTTA Technology Summit

April 30, 2026

Momcozy Launches Clinically Tested Skincare Solutions for Breast and Belly Care

April 30, 2026

Poland Data Center Colocation Market Set to Double in Size During 2026-2030: Analysis of Emerging Investment Opportunities

April 30, 2026

Latest News

UAE Data Center Colocation Market Databook Q2 2026: Hyperscale Investments Position UAE as Regional Cloud Gateway

April 30, 2026

RCMP ask for ‘specific’ tips to help find missing Nova Scotia kids

April 30, 2026

Asset Preservation Wealth & Tax Expands Southeast Presence with New Greenville, South Carolina, Office

April 30, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version